Bill Text: WV HB4150 | 2024 | Regular Session | Introduced
Bill Title: Authorizing the West Virginia Board of Pharmacy to promulgate a legislative rule relating to substitution of biological pharmaceuticals
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced) 2024-02-08 - To House Judiciary [HB4150 Detail]
Download: West_Virginia-2024-HB4150-Introduced.html
WEST VIRGINIA LEGISLATURE
2024 REGULAR SESSION
Introduced
House Bill 4150
By Delegate Smith
[Introduced January 10, 2024; Referred
to Committee on Health and Human Resources then the Judiciary]
A BILL to amend and reenact §64-9-1 of the Code of West Virginia, 1931, as amended, relating to authorizing the West Virginia Board of Pharmacy to promulgate a legislative rule relating to substitution of biological pharmaceuticals.
Be it enacted by the Legislature of West Virginia:
ARTICLE 9. Authorization for miscellaneous boards and agencies to promulgate legislative rules.
§64- 9 - 1. West Virginia Board of Pharmacy.
The legislative rule filed in the State Register on July 20, 2023, authorized under the authority of §30-5-7 of this code, relating to the West Virginia Board of Pharmacy (Board of Pharmacy rules for the substitution of biological pharmaceuticals, 15 CSR 17), is authorized.
NOTE: The purpose of this bill is to authorize the West Virginia Board of Pharmacy to promulgate a legislative rule relating to substitution of biological pharmaceuticals.
Strike-throughs indicate language that would be stricken from a heading or the present law and underscoring indicates new language that would be added.